Adult Intake System
TriageIQ™
Universal Chronic Screener
Find it First. Find it Fast.
TriageIQ™ | The Universal Chronic Disease Screener.
Adult Intake System
TriageIQ™
Universal Chronic Screener
Find it First. Find it Fast.
Screen Adults (45+ Years) for Chronic Diseases
TriageIQ™ is the only validated 1–2 minute clinical instrument designed for use during adult patient intake, identifying early neurological, cardiometabolic, and behavioral risk signals across the full spectrum of chronic disease.
Built as the missing aggregation layer in chronic care, this proprietary system captures early risk signals across the chronic disease or suspected chronic patients population helping providers detect what others miss and initiate the clinical pathways that follow. TriageIQ™ is appropriate for adult patients, with a clinical urgency for patients 45 and older where chronic disease burden, neurological risk, and behavioral health impact converge most significantly.
"In initial clinical use, providers identified an average of 2 additional reimbursable assessments per patient visit using TriageIQ™ as their intake screener — assessments that would otherwise have gone undocumented and unbilled." — Clinical Implementation Findings, Diabetes Testing Centers™
Patients can complete TriageIQ™ screenings on-site or remotely— no special equipment required.
TriageIQ™ is a proprietary, evidence-based Universal Chronic Screener that requires no equipment, no specialized training, and adds virtually no time to clinical workflow. In just 1–2 minutes it produces structured, objective results and a documented clinical pathway that supports appropriate follow-up care.
Developed over several years in clinical settings by Diabetes Testing Centers™ (DTC), TriageIQ™ can be deployed seamlessly in-clinic, remotely, through telemedicine, digital platforms, or integrated into AI voice systems. During a single screening interaction, it identifies early risk signals across three major chronic disease domains.
Neurological Risk. Silent nerve and brain changes — including cognitive decline, neuropathy, and fall risk — often appear years before symptoms. Early detection allows providers to intervene before irreversible damage occurs.
Cardiometabolic Risk. Hypertension, diabetes complications, and vascular disease frequently progress without warning. Early screening reduces the risk of heart attack, stroke, and serious complications.
Behavioral Risk. Depression, sleep disorders, and behavioral health conditions directly worsen chronic disease outcomes. Early identification enables timely support and coordinated care.
Unlike screening tools focused on a single condition or specialty, TriageIQ™ evaluates three domains simultaneously. This integrated approach transforms routine patient encounters into structured, Medicare-ready clinical events that identify risk earlier and support appropriate downstream care pathways, including cognitive assessments, behavioral health evaluations, and individualized care planning.
TriageIQ™ Identifies Signs for Behavioral and Cognitive Assessments.
Find it First. Find it Fast.
Most neurological, cardiometabolic, and behavioral risk in chronic disease patients goes undetected until significant damage has already occurred. TriageIQ™ addresses this gap by giving providers a fast, objective, and documentable Universal Chronic Screener that identifies at-risk patients earlier, when intervention is still most effective and complications are still preventable.
Traditional screening tools are typically applied only when risk is already suspected. This selective approach overlooks a large portion of the chronic disease population because neurological, cardiometabolic, and behavioral changes often develop silently for years before symptoms become obvious. By the time symptoms appear, meaningful damage may already be present. Waiting for symptoms is not early detection — it is late response.
TriageIQ™ was designed to change that model. The screening takes just 1–2 minutes and can be embedded into routine clinical intake, telehealth visits, chronic care outreach, or other patient interactions. By applying the screener universally rather than selectively, providers gain a consistent method for identifying early risk signals across their entire chronic patient population.
Our universal screening approach allows clinics to:
• ensure no patients are overlooked due to time constraints or assumptions
• identify early neurological, cardiometabolic, and behavioral risk signals
• generate structured documentation for every screening interaction
• establish medical necessity before additional assessments are performed
• transform routine chronic care encounters into documented screening events
The clinical rationale for this approach is well supported. Research consistently shows that neurological, cardiometabolic, and behavioral decline in chronic disease populations — particularly those with diabetes, cardiovascular disease, hypertension, and metabolic syndrome — often begins years before clinical symptoms appear. A universal screening model is therefore essential to detect these risks early and at the scale required for modern chronic care programs.
Alzheimer's is Underdiagnosed & Undertreated
TriageIQ™ Identifies Conditions that Support Additional Care Pathways.
Standardize Adult Screenings
Medicare Documentation Is Under Greater Scrutiny. Medicare documentation requirements have become significantly stricter. CMS increasingly expects providers to demonstrate a clear clinical pathway showing why neurological, cardiometabolic, or behavioral testing was medically necessary. General observations, brief intake notes, or vague staff documentation often fail to meet this standard during audits.
When practices cannot produce structured, visit-level evidence supporting medical necessity, they face growing exposure to claim denials, recoupments, and compliance risk that can erode both revenue and reputation.
TriageIQ™ Addresses This Requirement in 1–2 Minutes
In a single interaction, TriageIQ™ generates structured documentation capturing neurological, cardiometabolic, and behavioral risk indicators. The result is a standardized record that supports clinical decision-making and demonstrates medical necessity when further evaluation is performed. Unlike informal intake processes or subjective staff observations, TriageIQ™ produces consistent, structured output that aligns with the expectations of payers, compliance reviewers, and auditors — helping close the documentation gap before it becomes a liability.
Built for Any Clinical Workflow
TriageIQ™ can be deployed through paper forms, voice agents, text links, EHR systems, or telemedicine platforms, allowing it to integrate into virtually any care environment. Primary care clinics, health systems, RPM programs, behavioral health providers, and specialty practices can implement the screening without disrupting existing workflows.
There is no lengthy implementation, no major staff retraining, and no dependency on a single technology platform. Whether a clinic operates on a legacy EHR, conducts outreach by phone, or delivers care through telemedicine, TriageIQ™ adapts to the workflow already in place.
Applied Across the Entire Adult Patient Population
TriageIQ™ is not limited to patients with established chronic disease. Most screening tools are used reactively — only after a diagnosis has already been made. TriageIQ™ is designed to screen adult patients broadly so providers can identify neurological, cardiometabolic, and behavioral risk signals earlier in the disease process.
TriageIQ™ can be applied across many types of patient encounters, including:
chronic patients
suspected chronic patients
pre-chronic patients
wellness visits
surgical patients
telehealth visits
CCM outreach calls
RPM monitoring interactions
By applying a consistent screening layer across these encounters, providers can detect early chronic disease risk while strengthening documentation and guiding appropriate clinical evaluation.
Screen Adults on Every Visit
TriageIQ™ is a trademark of Medrano & Associates LLC dba Diabetes Testing Centers™. All rights reserved. Proprietary screening methodology is protected intellectual property.